approval · primary record
TAFASITAMAB-CXIX
FDA · BLA · 2025-06-18
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2025-06-18 |
| Brand | MONJUVI |
| Sponsor | MORPHOSYS US INC |
| Route | INTRAVENOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T03:30:26.688Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:TAFASITAMAB-CXIX:2025-06-18
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.